Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Y-26763 protects against ischemia/reperfusion injury in dog model

May 26, 1997

Pfizer sponsors large cardiovascular trial in U.K. and Scandinavia

May 26, 1997

Potent, nonpeptide ECE-1/NEP inhibitor discovered by Novartis

May 26, 1997

Mylan receives FDA approval of generic captopril/hydrochlorothiazide

May 23, 1997

Schwarz Pharma and LocalMed work together on antirestenosis drug

May 23, 1997

Disappointing phase III results for Bayer anti-TNF antibody

May 22, 1997

FDA reschedules review date for Heart Laser

May 22, 1997

UR-12670 effective in rat model of endotoxic shock

May 22, 1997

Na+/H+ exchange inhibitors reported by Hoechst

May 22, 1997

Additional GUSTO III data supports efficacy and safety of Retavase

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...